<?xml version="1.0" encoding="UTF-8"?>
<ref id="mbt213592-bib-0048">
 <mixed-citation publication-type="journal" id="mbt213592-cit-0048">
  <string-name>
   <surname>Monteil</surname>, 
   <given-names>V.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kwon</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Prado</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hagenkrüys</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wimmer</surname>, 
   <given-names>R.A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Stahl</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <italic>et al</italic> (
  <year>2020</year>) 
  <article-title>Inhibition of SARS‐CoV‐2 infections in engineered human tissues using clinical‐grade soluble human ACE2</article-title>. 
  <source xml:lang="en">Cell</source> [Epub ahead of print]. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.004</pub-id>
 </mixed-citation>
</ref>
